FIRM FIXED PRICENO SET ASIDE USED.

BIOGEN U.S. CORPORATION - NEW AWARD FOR RANIBIZUMAB (BYOOVIZ) VIALS WITH BIOGEN U.S. CORPORATION. PERIOD OF PERFORMANCE IS 12/23/23 TO 12/22/24 WITH FOUR ONE-YEAR OPTIONS.

PIID: 36E79724D0002Solicitation ID: 36E79723R0018

Signed Date: Nov 25, 2025Effective Date: Dec 23, 2023

Vendor

BIOGEN U.S. CORPORATION

NAICS

325412

Signed Date

Nov 25, 2025

Key Details

Dollars Obligated

Base & All Options

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Description

NEW AWARD FOR RANIBIZUMAB (BYOOVIZ) VIALS WITH BIOGEN U.S. CORPORATION. PERIOD OF PERFORMANCE IS 12/23/23 TO 12/22/24 WITH FOUR ONE-YEAR OPTIONS.

Context & Analysis

On Nov 25, 2025, Department of Veterans Affairs to BIOGEN U.S. CORPORATION for new award for ranibizumab (byooviz) vials with biogen u.s. corporation. period of performance is 12/23/23 to 12/22/24 with four one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside.